Case Report: Nivolumab-Induced Autoimmune Pancreatitis

Nivolumab is an anti-programmed cell death protein 1 monoclonal antibody. While an effective treatment for a variety of tumors, immune checkpoint inhibitors (ICI) can cause immune-related adverse events such as ICI-pancreatic injury (ICI-PI). Here we present a case of a 60-year-old man with metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Preeya, Moyers, Justin T., Elgohary, Bassem G., Hammami, Muhammad B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Innovative Healthcare Institute 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138477/
https://www.ncbi.nlm.nih.gov/pubmed/35665025
http://dx.doi.org/10.36401/JIPO-21-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138477/
https://www.ncbi.nlm.nih.gov/pubmed/35665025
http://dx.doi.org/10.36401/JIPO-21-11

Ejemplares similares